Trace amine-associated receptor 1 (TAAR1): a new drug target for psychiatry?

Dodd, Seetal, Carvalho, André F, Puri, Basant K, Maes, Michael, Bortolasci, Chiara C, Morris, Gerwyn and Berk, Michael 2021, Trace amine-associated receptor 1 (TAAR1): a new drug target for psychiatry?, Neuroscience and biobehavioral reviews, vol. 120, pp. 537-541, doi: 10.1016/j.neubiorev.2020.09.028.

Attached Files
Name Description MIMEType Size Downloads

Title Trace amine-associated receptor 1 (TAAR1): a new drug target for psychiatry?
Author(s) Dodd, SeetalORCID iD for Dodd, Seetal
Carvalho, André F
Puri, Basant K
Maes, Michael
Bortolasci, Chiara CORCID iD for Bortolasci, Chiara C
Morris, Gerwyn
Berk, MichaelORCID iD for Berk, Michael
Journal name Neuroscience and biobehavioral reviews
Volume number 120
Start page 537
End page 541
Total pages 5
Publisher Elsevier
Place of publication Amsterdam, The Netherlands
Publication date 2021-01
ISSN 0149-7634
Keyword(s) Science & Technology
Life Sciences & Biomedicine
Behavioral Sciences
Neurosciences & Neurology
Trace Amine-Associated Receptor
drug target
Language eng
DOI 10.1016/j.neubiorev.2020.09.028
Indigenous content off
Field of Research 11 Medical and Health Sciences
17 Psychology and Cognitive Sciences
HERDC Research category C1 Refereed article in a scholarly journal
Persistent URL

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 5 times in TR Web of Science
Scopus Citation Count Cited 6 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 69 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Thu, 22 Oct 2020, 06:40:29 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact